Phibro Animal Health Corp PAHC.OQ reported quarterly adjusted earnings of 57 cents per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of 41 cents. The mean expectation of three analysts for the quarter was for earnings of 52 cents per share. Wall Street expected results to range from 50 cents to 54 cents per share.
Revenue rose 38.6% to $378.70 million from a year ago; analysts expected $362.24 million.
Phibro Animal Health Corp's reported EPS for the quarter was 42 cents.
The company reported quarterly net income of $17.2 million.
Phibro Animal Health Corp shares had risen by 27.8% this quarter and gained 55.4% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 1.9% in the last three months.
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy," 2 "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the pharmaceuticals peer group is "buy."
Wall Street's median 12-month price target for Phibro Animal Health Corp is $24.00, about 34.2% below its last closing price of $32.20
This summary was machine generated from LSEG data August 27 at 10:34 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Jun. 30 2025 | 0.52 | 0.57 | Beat |
Mar. 31 2025 | 0.52 | 0.63 | Beat |
Dec. 31 2024 | 0.43 | 0.54 | Beat |
Sep. 30 2024 | 0.25 | 0.35 | Beat |